Chia-Chi Lin Selected Research

Chia-Chi Lin Research Topics

Disease

69	Neoplasms (Cancer) 10/2022 - 09/2004
41	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 05/2008
13	Esophageal Squamous Cell Carcinoma 10/2022 - 07/2007
13	Carcinoma (Carcinomatosis) 01/2020 - 09/2004
12	Neoplasm Metastasis (Metastasis) 06/2022 - 03/2007
12	Disease Progression 02/2022 - 06/2016
8	Esophageal Neoplasms (Esophageal Cancer) 07/2022 - 11/2002
7	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 02/2007
7	Adenocarcinoma 01/2020 - 11/2015
7	Lung Neoplasms (Lung Cancer) 01/2020 - 09/2014
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 03/2006
5	Diarrhea 09/2021 - 03/2013
5	Fatigue 09/2021 - 10/2016
5	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 01/2017
4	Squamous Cell Carcinoma of Head and Neck 02/2022 - 11/2016
3	Nausea 01/2022 - 03/2013
3	Thymoma (Thymic Carcinoma) 01/2022 - 01/2018
3	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2007
3	Exanthema (Rash) 09/2021 - 05/2009
3	Hypertension (High Blood Pressure) 01/2021 - 05/2009
3	Hemorrhage 01/2021 - 04/2018
3	Urinary Bladder Neoplasms (Bladder Cancer) 11/2019 - 10/2009
3	Infections 12/2017 - 06/2002
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017 - 11/2015
2	Anaplastic Thyroid Carcinoma 06/2022 - 10/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2020
2	Febrile Neutropenia 12/2020 - 08/2011
2	Adenocarcinoma of Lung 01/2020 - 01/2020
2	Lymphoma (Lymphomas) 01/2019 - 08/2015
2	Thrombocytopenia (Thrombopenia) 01/2019 - 08/2011
2	Stomach Neoplasms (Stomach Cancer) 09/2017 - 06/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2014 - 03/2013
2	Carcinogenesis 07/2008 - 01/2006

Drug/Important Bio-Agent (IBA)

24	ErbB Receptors (EGF Receptor)IBA 01/2020 - 03/2006
22	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 11/2002
20	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2009
12	Paclitaxel (Taxol)FDA LinkGeneric 07/2022 - 03/2006
12	Gefitinib (Iressa)FDA Link 01/2017 - 03/2006
11	Fluorouracil (Carac)FDA LinkGeneric 06/2019 - 11/2002
8	Leucovorin (Folinic Acid)FDA Link 06/2019 - 11/2002
8	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 05/2009
7	B7-H1 AntigenIBA 07/2022 - 11/2016
7	pembrolizumabIBA 06/2022 - 06/2016
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 09/2010
6	Anaplastic Lymphoma KinaseIBA 01/2022 - 09/2015
5	PlatinumIBA 01/2022 - 10/2011
5	lorlatinibIBA 01/2022 - 12/2018
5	Pharmaceutical PreparationsIBA 09/2021 - 11/2017
5	AfatinibIBA 01/2017 - 03/2016
4	spartalizumabIBA 06/2022 - 01/2020
4	LigandsIBA 02/2022 - 11/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2013
4	osimertinibIBA 01/2021 - 01/2017
4	Gemcitabine FDA Link 08/2018 - 04/2007
3	Alkaline PhosphataseIBA 01/2022 - 03/2007
3	Immune Checkpoint InhibitorsIBA 12/2021 - 10/2019
3	Phosphotransferases (Kinase)IBA 10/2021 - 04/2014
3	Proteins (Proteins, Gene)FDA Link 05/2021 - 11/2019
3	Monoclonal AntibodiesIBA 05/2021 - 09/2017
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021 - 06/2014
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 11/2017
3	cabozantinibIBA 01/2021 - 02/2013
3	RamucirumabIBA 01/2021 - 01/2020
3	CrizotinibIBA 01/2020 - 12/2018
3	Arsenic Trioxide (Trisenox)FDA Link 11/2008 - 09/2004
3	Methotrexate (Mexate)FDA LinkGeneric 01/2007 - 11/2002
2	sapanisertibIBA 05/2022 - 01/2022
2	siremadlinIBA 03/2022 - 01/2022
2	AntibodiesIBA 01/2022 - 05/2021
2	LY3300054IBA 12/2021 - 01/2021
2	trastuzumab deruxtecanIBA 11/2021 - 10/2021
2	entrectinibIBA 10/2021 - 01/2020
2	pexidartinibIBA 01/2021 - 01/2020
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 06/2014
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 10/2016
2	Alanine Transaminase (SGPT)IBA 01/2020 - 11/2017
2	Epidermal Growth Factor (EGF)IBA 11/2019 - 09/2010
2	NivolumabIBA 01/2018 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 08/2011
2	Dihydrotachysterol (AT 10)IBA 11/2016 - 05/2009
2	Pemetrexed (MTA)FDA Link 03/2016 - 09/2014
2	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 06/2014 - 03/2013
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 06/2014 - 03/2013
2	Drug CombinationsIBA 09/2013 - 07/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2013 - 05/2009
2	Bevacizumab (Avastin)FDA Link 01/2013 - 05/2009
2	Oxidoreductases (Dehydrogenase)IBA 08/2011 - 01/2009

Therapy/Procedure

32	Therapeutics 10/2022 - 04/2007
26	Drug Therapy (Chemotherapy) 01/2022 - 11/2002
7	Chemoradiotherapy 08/2019 - 10/2009
6	Esophagectomy 08/2019 - 06/2009
5	Neoadjuvant Therapy 07/2022 - 06/2009
4	Induction Chemotherapy 11/2019 - 10/2009
4	Radiotherapy 08/2018 - 06/2009
3	Immunotherapy 06/2022 - 01/2018
3	Castration 01/2022 - 02/2013
3	Combination Drug Therapy (Combination Chemotherapy) 01/2014 - 11/2002
2	Duration of Therapy 02/2022 - 11/2017
2	TP protocol 06/2019 - 01/2007